A Clinical Study of HRS-8797 in Healthy Participants
NCT07698756 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 74
Last updated 2026-07-13
Summary
The purpose of this phase I study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-8797 in healthy participants.
Conditions
Interventions
- DRUG
-
HRS-8797
Specified dose on specified days
- DRUG
-
Specified dose on specified days
Sponsors & Collaborators
-
Chengdu Suncadia Medicine Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-07-31
- Primary Completion
- 2026-12-31
- Completion
- 2027-01-31
Countries
- China
Study Locations
More Related Trials
-
A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis
NCT00703573 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
NCT04717310 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
NCT06863961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms
NCT06268847 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis
NCT07370909 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
NCT06775860 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
NCT05549947 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis
NCT07103369 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
NCT07211542 ·Status: RECRUITING ·Phase: PHASE2
-
A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis
NCT04271514 ·Status: COMPLETED ·Phase: PHASE1
-
Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis
NCT06553209 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers
NCT05718921 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis
NCT07321951 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants
NCT07488065 ·Status: RECRUITING ·Phase: PHASE1
-
Phase 2 Study of KHK4577
NCT02004119 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis
NCT04162899 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
NCT07309055 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
NCT06931990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
NCT06947993 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis
NCT04179760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of LW402 in Moderate-to-Severe Atopic Dermatitis
NCT07186387 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis
NCT02424253 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis
NCT00980629 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis
NCT07015762 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
NCT07239947 ·Status: RECRUITING ·Phase: PHASE1